Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 107

1.

Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplantation: Management Principles.

Smibert O, Satlin MJ, Nellore A, Peleg AY.

Curr Infect Dis Rep. 2019 Jun 10;21(7):26. doi: 10.1007/s11908-019-0679-4. Review.

PMID:
31183574
2.

Biofilm formation and migration on ventricular assist device drivelines.

Qu Y, McGiffin D, Kure C, Ozcelik B, Fraser J, Thissen H, Peleg AY.

J Thorac Cardiovasc Surg. 2019 Mar 6. pii: S0022-5223(19)30556-2. doi: 10.1016/j.jtcvs.2019.02.088. [Epub ahead of print]

PMID:
30955967
3.

A population-based analysis of invasive fungal disease in haematology-oncology patients using data linkage of state-wide registries and administrative databases: 2005 - 2016.

Valentine JC, Morrissey CO, Tacey MA, Liew D, Patil S, Peleg AY, Ananda-Rajah MR.

BMC Infect Dis. 2019 Mar 21;19(1):274. doi: 10.1186/s12879-019-3901-y.

4.

Antibiotic resistance and host immune evasion in Staphylococcus aureus mediated by a metabolic adaptation.

Jiang JH, Bhuiyan MS, Shen HH, Cameron DR, Rupasinghe TWT, Wu CM, Le Brun AP, Kostoulias X, Domene C, Fulcher AJ, McConville MJ, Howden BP, Lieschke GJ, Peleg AY.

Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3722-3727. doi: 10.1073/pnas.1812066116. Epub 2019 Feb 11.

PMID:
30808758
5.

Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems.

Gardiner BJ, Stewardson AJ, Abbott IJ, Peleg AY.

Aust Prescr. 2019 Feb;42(1):14-19. doi: 10.18773/austprescr.2019.002. Epub 2019 Feb 1. Review. No abstract available.

6.

Fatal disseminated visceral varicella zoster virus infection in a renal transplant recipient.

Loftus MJ, Yong MK, Wilson S, Peleg AY.

Transpl Infect Dis. 2019 Jun;21(3):e13062. doi: 10.1111/tid.13062. Epub 2019 Mar 7.

PMID:
30756453
7.

Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia.

Rees VE, Deveson Lucas DS, López-Causapé C, Huang Y, Kotsimbos T, Bulitta JB, Rees MC, Barugahare A, Peleg AY, Nation RL, Oliver A, Boyce JD, Landersdorfer CB.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02538-18. doi: 10.1128/AAC.02538-18. Print 2019 Apr.

PMID:
30745381
8.

Identification of Novel Acinetobacter baumannii Host Fatty Acid Stress Adaptation Strategies.

Jiang JH, Hassan KA, Begg SL, Rupasinghe TWT, Naidu V, Pederick VG, Khorvash M, Whittall JJ, Paton JC, Paulsen IT, McDevitt CA, Peleg AY, Eijkelkamp BA.

MBio. 2019 Feb 5;10(1). pii: e02056-18. doi: 10.1128/mBio.02056-18.

9.

Evolution of Daptomycin Resistance in Coagulase-Negative Staphylococci Involves Mutations of the Essential Two-Component Regulator WalKR.

Jiang JH, Dexter C, Cameron DR, Monk IR, Baines SL, Abbott IJ, Spelman DW, Kostoulias X, Nethercott C, Howden BP, Peleg AY.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e01926-18. doi: 10.1128/AAC.01926-18. Print 2019 Mar.

PMID:
30617095
10.

OXA-23 Is a Prevalent Mechanism Contributing to Sulbactam Resistance in Diverse Acinetobacter baumannii Clinical Strains.

Yang Y, Xu Q, Li T, Fu Y, Shi Y, Lan P, Zhao D, Chen Q, Zhou Z, Jiang Y, Peleg AY, Yu Y.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01676-18. doi: 10.1128/AAC.01676-18. Print 2019 Jan. No abstract available.

11.

A Randomized Study of Quantiferon CMV-directed Versus Fixed-duration Valganciclovir Prophylaxis to Reduce Late CMV After Lung Transplantation.

Westall GP, Cristiano Y, Levvey BJ, Whitford H, Paraskeva MA, Paul E, Peleg AY, Snell GI.

Transplantation. 2019 May;103(5):1005-1013. doi: 10.1097/TP.0000000000002454.

PMID:
30247316
12.

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.

Harris PNA, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M, Alenazi TH, Arabi Y, Falcone M, Bassetti M, Righi E, Rogers BA, Kanj S, Bhally H, Iredell J, Mendelson M, Boyles TH, Looke D, Miyakis S, Walls G, Al Khamis M, Zikri A, Crowe A, Ingram P, Daneman N, Griffin P, Athan E, Lorenc P, Baker P, Roberts L, Beatson SA, Peleg AY, Harris-Brown T, Paterson DL; MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN).

JAMA. 2018 Sep 11;320(10):984-994. doi: 10.1001/jama.2018.12163. Erratum in: JAMA. 2019 Jun 18;321(23):2370.

13.

Comprehensive antibiotic-linked mutation assessment by resistance mutation sequencing (RM-seq).

Guérillot R, Li L, Baines S, Howden B, Schultz MB, Seemann T, Monk I, Pidot SJ, Gao W, Giulieri S, Gonçalves da Silva A, D'Agata A, Tomita T, Peleg AY, Stinear TP, Howden BP.

Genome Med. 2018 Aug 31;10(1):63. doi: 10.1186/s13073-018-0572-z.

14.

Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients.

Rees VE, Yadav R, Rogers KE, Bulitta JB, Wirth V, Oliver A, Boyce JD, Peleg AY, Nation RL, Landersdorfer CB.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01150-18. doi: 10.1128/AAC.01150-18. Print 2018 Nov.

15.

Spectrum of illness among returned Australian travellers from Bali, Indonesia: a 5-year retrospective observational study.

Sohail A, McGuinness SL, Lightowler R, Leder K, Jomon B, Bain CA, Peleg AY.

Intern Med J. 2019 Jan;49(1):34-40. doi: 10.1111/imj.13993.

PMID:
29869360
16.

In vivo atomic force microscopy-infrared spectroscopy of bacteria.

Kochan K, Perez-Guaita D, Pissang J, Jiang JH, Peleg AY, McNaughton D, Heraud P, Wood BR.

J R Soc Interface. 2018 Mar;15(140). pii: 20180115. doi: 10.1098/rsif.2018.0115.

17.

Evolution of carbapenem resistance in Acinetobacter baumannii during a prolonged infection.

Hawkey J, Ascher DB, Judd LM, Wick RR, Kostoulias X, Cleland H, Spelman DW, Padiglione A, Peleg AY, Holt KE.

Microb Genom. 2018 Mar;4(3). doi: 10.1099/mgen.0.000165. Epub 2018 Mar 16.

18.

Elucidation of the pharmacokinetic/pharmacodynamic determinants of fosfomycin activity against Pseudomonas aeruginosa using a dynamic in vitro model.

Bilal H, Peleg AY, McIntosh MP, Styles IK, Hirsch EB, Landersdorfer CB, Bergen PJ.

J Antimicrob Chemother. 2018 Jun 1;73(6):1570-1578. doi: 10.1093/jac/dky045.

PMID:
29506207
19.

Optimization of a Meropenem-Tobramycin Combination Dosage Regimen against Hypermutable and Nonhypermutable Pseudomonas aeruginosa via Mechanism-Based Modeling and the Hollow-Fiber Infection Model.

Landersdorfer CB, Rees VE, Yadav R, Rogers KE, Kim TH, Bergen PJ, Cheah SE, Boyce JD, Peleg AY, Oliver A, Shin BS, Nation RL, Bulitta JB.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02055-17. doi: 10.1128/AAC.02055-17. Print 2018 Apr.

20.

Convergent Evolution Driven by Rifampin Exacerbates the Global Burden of Drug-Resistant Staphylococcus aureus.

Guérillot R, Gonçalves da Silva A, Monk I, Giulieri S, Tomita T, Alison E, Porter J, Pidot S, Gao W, Peleg AY, Seemann T, Stinear TP, Howden BP.

mSphere. 2018 Jan 24;3(1). pii: e00550-17. doi: 10.1128/mSphere.00550-17. eCollection 2018 Jan-Feb.

Supplemental Content

Loading ...
Support Center